Shares of Sun Pharmaceutical Industries Ltd. 524715 inched down 0.31% to 1,803.25 Indian rupees Tuesday, on what proved to be ...

Most brokerages retained ratings and target prices for Sun Pharmaceutical Industries after its second quarter earnings beat ...

How will India’s leading drugmaker handle legal setbacks, volatile market trends, and competition in generics and specialty products?

In the worst-case scenario, an unfavourable judgment would prevent Sun Pharma from launching Leqselvi until the patent expires, delaying its market entry.

Shares of Sun Pharmaceutical fell 2.64 per cent after the pharma major recently announced that the US District Court of ...

Pharma giant, Sun Pharmaceutical's launch of its specialty drug Leqselvi in the U.S. market is in limbo as the U.S. District Court in New Jersey has issued a preliminary injunction.

Sun Pharmaceutical Industries reported a 28% rise in net profit, reaching Rs 3,040 crore for the September quarter, driven by ...

Sun Pharmaceuticals , India's largest drugmaker by revenue, reported second-quarter profit above analysts' estimates on ...

Analysts expected India's largest drugmaker's net profit to jump, led by favourable seasonality and strong specialty sales.

Sun Pharmaceutical Industries has reported a notable 28% increase in its consolidated net profit, amounting to Rs 3,040 crore ...

Mumbai: Indoco Remedies has announced the appointment of Vaibhav Sinha as Senior Management Personnel designated as Vice ...